Buda Juice heads into its next report with a strange mismatch between what management said and what the market seems to believe. Three months ago, executives described a business whose growth was accelerating faster than planned, with early third-quarter sales running more than 40% above the prior year. Since then the stock has fallen about 24%, trailing the S&P 500 by nearly 19 percentage points. Either the market is discounting that growth claim, or it is far more worried about the cost of getting there. The report due after the close on November 12 should settle which concern deserves more weight.

The Street is not asking for much. Consensus calls for earnings of $0.02 per share, half the $0.04 posted last quarter, on revenue of roughly $4.4 million. That revenue figure sits slightly below the $4.5 million the company booked in its fiscal second quarter, which looks conservative against management's comment that sales in the first six weeks of the current period were up more than 40% year over year, with about half of that coming from organic same-store gains. There is no formal guidance to anchor the comparison, and those early figures were preliminary and unaudited, but a flat-to-down sequential revenue estimate leaves meaningful room for an upside surprise if the momentum held. The lower earnings bar, meanwhile, reflects expectations that margins stay under pressure.

That pressure is the core of the debate. Gross margin slid to 36.6% last quarter from 39.5% in the first quarter and 46.7% a year earlier, a decline of more than 1,000 basis points. Management attributed most of it to identifiable sources: about 320 basis points from outsourced co-packing for the new Ultra Fresh Dressings line, roughly 270 from inbound freight, around 290 from elevated lime costs, plus training labor and mix. Limes have reportedly normalized, so a modest gross margin recovery this quarter would support the argument that the squeeze is temporary. Co-packing costs, however, are expected to persist until dressing production moves in-house to the Dallas plant in early 2027, and freight has no defined end date. If gross margin fails to improve even with lime costs easing, the transitory framing starts to look less convincing.

The growth story has several pieces that deserve evidence. Buddha Fresh is now in 246 Walmart stores across nine states, and management highlighted one early store where its section may be outselling the adjacent pasteurized juice set. Investors should look for signs that this is a repeatable pattern rather than an anecdote, ideally through same-store figures that continue the climb from roughly 4% to 17% to 26% over the past three quarters. The dressings launch, aimed at a ranch category management sized at around $2 billion, also needs follow-through in the form of new customers, since several were said to be in discussion.

Cash flow is another checkpoint. Free cash flow swung to negative $0.8 million last quarter, which management tied to a one-time receivables increase after a customer abandoned early-pay discounts and to dressing-line capital spending. A return toward positive cash generation would ease concerns, especially with operating expenses having risen to nearly 27% of revenue amid new public-company and tax costs.

Sentiment is decidedly bearish, and the stock at $6.55 sits only about 5% above its post-report low of $6.25, the same floor it hit the prior quarter, while well off the $9.65 high. That pessimism lowers the bar, but it also signals little patience for further margin slippage. The central question is whether revenue growth confirms the 40%-plus pace management previewed while gross margin stabilizes. Delivering both would validate the story that today's compression is an investment phase; strong sales with still-shrinking margins would suggest growth is coming at a steeper price than promised.